Medtronic 2014 Annual Report Download - page 17

Download and view the complete annual report

Please find page 17 of the 2014 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 147

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147

conditions of ENT. Our Aquamantys System uses patented Transcollation technology to provide haemostatic sealing of soft
tissue and bone and is cleared for use in a variety of surgical procedures, including orthopedic surgery, spine, solid organ
resection and thoracic procedures.
The charts below set forth net sales of our Surgical Technologies products as a percentage of our total net sales for each of the
last three fiscal years:
Fiscal Year 2012
(dollars in millions)
Surgical Technologies
$1,254
All Other
$14,930
Fiscal Year 2013
(dollars in millions)
All Other
$15,164
Surgical Technologies
$1,426
Fiscal Year 2014
(dollars in millions)
All Other
$15,443
Surgical Technologies
$1,562
9%
91%
9%
91%
8%
92%
Customers and Competitors
The primary customers for our products relating to ENT diseases and conditions are ENT surgeons and the hospitals and clinics
where they perform surgery. Competitors in this part of our Surgical Technologies business include Gyrus ACMI (a group
company of Olympus Corporation), Stryker, and Johnson & Johnson.
The primary customers for our neurosurgical products are neurosurgeons, spinal surgeons, and the hospitals and clinics where
they perform surgery. Competitors include Johnson & Johnson, Stryker, Zimmer, and Integra LifeSciences Holdings
Corporation. The primary customers for our image-guided surgery and intra-operative imaging systems are hospitals and clinics.
Competitors include BrainLAB, Inc., Stryker, GE Healthcare, Siemens Medical Solutions USA, Inc., and Philips Medical
Systems.
The primary customers for our advanced energy products are orthopedic surgeons, spinal surgeons, neurosurgeons, general
surgeons, electro physiologists, and the hospitals and clinics where they perform surgery. Competitors include Johnson &
Johnson, Covidien Plc, ArthroCare Corporation, a Smith & Nephew plc company, Olympus Corporation, Stryker, Conmed
Corporation, and B. Braun Medical Inc.
DIABETES GROUP
Our Diabetes business develops, manufactures, and markets advanced, integrated diabetes management solutions that include
insulin pump therapy, continuous glucose monitoring (CGM) systems, and therapy management software.
The following are the principal products offered by our Diabetes business:
Integrated Diabetes Management Solutions. We have the only integrated insulin pump and CGM system in the world. In the
U.S., we offer the MiniMed 530G System featuring our threshold suspend technology, which automatically suspends insulin
delivery when glucose levels reach a pre-determined threshold, and newest CGM sensor, Enlite, which is labeled for 6-days and
is more comfortable, more accurate, and smaller than our previous generation sensor. Outside the U.S., we offer our Paradigm
Veo System, an integrated system that includes the Low Glucose Suspend feature and is labeled for use with Enlite.
Professional CGM. In addition to Personal CGM (Enlite), we offer physicians a Professional CGM product called the
iPro2/iPro Professional CGM System. Physicians send patients home wearing the iPro2/iPro recorder to capture glucose data,
which is later uploaded in a physician’s office to reveal glucose patterns and potential problems, including hyperglycemic and
hypoglycemic episodes, which can lead to more informed treatment decisions.
CareLink Therapy Management Software. We offer web-based therapy management software solutions, including CareLink
Personal software for patients and CareLink Pro software, to help patients and their health care providers control their diabetes.
9